| MolName | (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-2-oxo-5-[(4-phenylmethoxyphenyl)methyl]pyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide |
| MolecularFormula | C46H48N2O5 |
| Smiles | O[C@@H](C[C@@H](Cc1ccccc1)C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)CN([C@@H](Cc(cc1)ccc1OCc1ccccc1)C[C@@H]1Cc2ccccc2)C1=O |
| InChI | InChI=1S/C46H48N2O5/c49-40(28-37(24-32-12-4-1-5-13-32)45(51)47-44-42-19-11-10-18-36(42)29-43(44)50)30-48-39(27-38(46(48)52)25-33-14-6-2-7-15-33)26-34-20-22-41(23-21-34)53-31-35-16-8-3-9-17-35/h1-23,37-40,43-44,49-50H,24-31H2,(H,47,51)/t37-,38+,39-,40+,43- |
| InChIK | LABLLUMGCSURSL-ZAQQJPAKSA-N |
| TotalMolweight | 708.896 |
| Molweight | 708.896 |
| MonoisotopicMass | 708.356323 |
| CLogP | 7.2525 |
| CLogS | -7.411 |
| H Acceptors | 7 |
| H Donors | 3 |
| TotalSurfaceArea | 550.34 |
| Relative PSA | 0.14044 |
| PolarSurfaceArea | 99.1 |
| Druglikeness | 5.4463 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.45283 |
| Fragments | 1 |
| Non HAtoms | 53 |
| NonCHAtoms | 7 |
| Electronegative Atoms | 7 |
| StereoCenters | 6 |
| Rotatable Bond | 15 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 5 |
| Aromatic Atoms | 30 |
| Sp3Atoms | 17 |
| Symmetricatoms | 8 |
| Amides | 2 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-2-oxo-5-[(4-phenylmethoxyphenyl)methyl]pyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide | 2 - (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-2-oxo-5-[(4-phenylmethoxyphenyl)methyl]pyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide